Orthofix Medical Inc. (NASDAQ:OFIX) Shares Purchased by AQR Capital Management LLC

AQR Capital Management LLC lifted its holdings in shares of Orthofix Medical Inc. (NASDAQ:OFIX) by 4.4% in the second quarter, HoldingsChannel.com reports. The firm owned 31,863 shares of the medical device company’s stock after acquiring an additional 1,336 shares during the quarter. AQR Capital Management LLC’s holdings in Orthofix Medical were worth $423,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. nVerses Capital LLC purchased a new stake in Orthofix Medical during the 2nd quarter worth about $27,000. Quest Partners LLC purchased a new stake in Orthofix Medical during the 2nd quarter valued at approximately $64,000. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Orthofix Medical by 25.5% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,435 shares of the medical device company’s stock worth $125,000 after buying an additional 1,919 shares during the last quarter. Arizona State Retirement System purchased a new stake in Orthofix Medical in the 2nd quarter valued at approximately $139,000. Finally, XTX Topco Ltd purchased a new stake in shares of Orthofix Medical during the 2nd quarter worth approximately $175,000. 89.76% of the stock is currently owned by institutional investors and hedge funds.

Orthofix Medical Trading Down 2.7 %

Shares of Orthofix Medical stock opened at $15.66 on Wednesday. The company has a debt-to-equity ratio of 0.24, a current ratio of 2.48 and a quick ratio of 1.13. The company has a market capitalization of $587.70 million, a P/E ratio of -4.63 and a beta of 1.05. The business has a 50 day moving average price of $16.22 and a 200 day moving average price of $14.90. Orthofix Medical Inc. has a 1 year low of $9.57 and a 1 year high of $17.67.

Orthofix Medical (NASDAQ:OFIX) last released its quarterly earnings data on Tuesday, August 6th. The medical device company reported ($0.88) EPS for the quarter, missing analysts’ consensus estimates of ($0.30) by ($0.58). Orthofix Medical had a negative return on equity of 20.68% and a negative net margin of 15.61%. The firm had revenue of $198.62 million during the quarter, compared to analysts’ expectations of $195.75 million. Sell-side analysts anticipate that Orthofix Medical Inc. will post -2.13 EPS for the current fiscal year.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.